发明名称 |
METHODS OF INDUCING A T CELL MEDIATED IMMUNE RESPONSE BY ADMINISTERING ANTIGEN PRESENTING B CELLS |
摘要 |
We teach a strategy to obtain large quantities of desired APCs, activated B cells, which are superior in their capacity to present tumor protein antigen in a multiadministration protocol. Human B cells can be obtained from peripheral blood in large numbers. These cells can be activated in vitro by coculture with CD40L (CD40-B cells) and an immunosuppressive agent such as cyclosporin A. They can expanded up to 1x10<SUP>3 </SUP>to 1x10<SUP>4 </SUP>fold in 2 weeks or 1x10<SUP>5 </SUP>to 1x10<SUP>6 </SUP>fold in 2 months. We demonstrate these cells are most efficient APCs comparable to DCs in stimulating allogeneic CD4<SUP>+</SUP> CD45RA<SUP>+</SUP>, CD4<SUP>+</SUP> CD45RO<SUP>+</SUP>, and CD8<SUP>+</SUP> T cells. In contrast to DCs, CD40-B cells are fully functional even in the presence of immunosuppressive cytokines such as IL-10 and TGFbeta.
|
申请公布号 |
US2007031811(A1) |
申请公布日期 |
2007.02.08 |
申请号 |
US20020186416 |
申请日期 |
2002.07.01 |
申请人 |
DANA-FARBER CANCER INSTITUTE, INC. |
发明人 |
SCHULTZE JOACHIM L.;FREEMAN GORDON J.;GRIBBEN JOHN G.;NADLER LEE M. |
分类号 |
A01N1/02;C12N5/02;C12N5/0781 |
主分类号 |
A01N1/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|